Clinical Characteristics of Giant Cell Tumour of Bone in Makassar, Indonesia

  • Futriani Department of Pathology Anatomy, Hasanuddin University, Makassar, Indonesia.
  • Muhammad P. Johan Department of Orthopedic and Traumatology, Faculty of Medicine, University of Hasanuddin, Makassar, Indonesia.
  • Ni Ketut Sungowati Department of Pathology Anatomy, Hasanuddin University, Makassar, Indonesia.
  • Andi A. Zainuddin Department of Public Health, Hasanuddin University, Makassar, Indonesia.
  • Djumadi Achmad Department of Pathology Anatomy, Hasanuddin University, Makassar, Indonesia.
  • Upik A. Miskad Department of Pathology Anatomy, Hasanuddin University, Makassar, Indonesia
Keywords: Giant cell tumor of bone, GCTB, clinical characteristics

Abstract

Giant Cell Tumor of Bone is a bone tumor that is classified as a benign tumor but is locally aggressive and can transform into malignant. Identification of the characteristics of GCTB is rarely done in Indonesia, especially in Makassar. This study determined the clinical characteristics of GCTB in Makassar from 2016 to 2021. This study used a descriptive method with total sampling and took samples from medical record data. We grouped GCTB clinical data which included patient age, gender, tumor location, tumor location distribution, histopathological examination then were grouped into benign and malignant GCTB. From 59 samples, most were at the age of 20-40 years (52.5%), especially in men (59.3%), the most common locations were in the long bones as many as 48 samples (81.4%) mainly in the distal radius, distal femur and proximal tibia. Benign cases were 56 samples (94.9%) and malignant cases were 3 samples (5.1%).

References

. Cheng, DD, Hu, T., Zhang, HZ, Huang, J., & Yang, QC (2015). Factors Affecting the Recurrence of Giant Cell Tumor of Bone after Surgery: A Clinicopathological Study of 80 Cases from a Single Center. Cellular Physiology and Biochemistry, 36(5), 1961–1970. https://doi.org/10.1159/000430164

. Noh, BJ, & Park, YK (2018). Giant cell tumor of bone: updated molecular pathogenesis and tumor biology. Human Pathology, 81, 1–8. https://doi.org/10.1016/j.humpath.2018.06.017

. Liede, A., Hernandez, RK, Tang, ET, Li, C., Bennett, B., Wong, SS, & Jandial, D. (2018). Epidemiology of benign giant cell tumor of bone in the Chinese population. Journal of Bone Oncology, 12, 96–100. https://doi.org/10.1016/j.jbo.2018.07.003

. Rosenberg, N. and. (2019). Diagnostic pathology Bone (secod edition). In Journal of Chemical Information and Modeling (Vol. 53, Issue 9).

. Sobti, A., Agrawal, P., Agarwala, S., & Agarwal, M. (2016). Giant cell tumor of bone - An overview. Archives of Bone and Joint Surgery, 4(1), 2–9. https://doi.org/10.22038/abjs.2016.4701

. David, & Fajar, A. (2006). The latest treatment for giant cell bone tumors (osteoclastoma). Universa Medicina, 25(2).

. Siddiqui, MA, Seng, C., & Tan, MH (2014). Risk factors for recurrence of giant cell tumors of bone. Journal of Orthopedic Surgery, 22(1), 108–110. https://doi.org/10.1177/230949901402200127

. Zheng, MH, Robbins, P., Xu, J., Huang, L., Wood, DJ, & Papadimitriou, JM (2001). The histogenesis of giant cell tumor of bone: A model of interaction between neoplastic cells and osteoclasts. Histology and Histopathology, 16(1), 297–307. https://doi.org/10.14670/HH-16.297

. Yamamoto, H., Ishihara, S., Toda, Y., & Oda, Y. (2020). Histone H3.3 mutation in giant cell tumor of bone: an update in pathology. Medical Molecular Morphology, 53(1). https://doi.org/10.1007/s00795-019-00238-1

. Unni, KK, & Inwards, CY (2010). Dahlin's Bone Tumors. Lippincott Williams & Wilkins

. Amri, R., Charfi, S., Jemaà, M., Miled, N., Slimi, F., Rebai, MA, Abdelwahed, M., Keskes, H., & Aifa, S. (2020). Significance of EGFR/HER2 Expression and PIK3CA Mutations in Giant Cell Tumor of Bone Development. BioMed Research International, 2020. https://doi.org/10.1155/2020/2931784

. He, Y., Zhang, J., & Ding, X. (2017). Prognosis of local recurrence in giant cell tumor of bone: what can we do? Radiologia Medica, 122(7), 505–519.https://doi.org/10.1007/s11547-017-0746-6

. Lokuhetty D, A. White V, ACI (Ed.). (2020). WHO Classification of Tumors Soft tissue and bone tumors (5th ed.). International Agency for Research on Cancer (IARC) 150 Cours Albert Thomas 69372 Lyon Cedex 08, France.https://doi.org/10.1017/CBO9780511545375.031

. Scotto, F., Whyte, MP, & Gianfrancesco, F. (2020). The two faces of giant cell tumor of bone. Cancer Letters, 489(May), 1–8.https://doi.org/10.1016/j.canlet.2020.05.031

. Cao, H., Lin, F., Hu, Y., Zhao, L., Yu, X., Wang, Z., Ye, Z., Wu, S., Guo, S., Zhang, G., & Wang, J. (2017). Epidemiological and Clinical Features of Primary Giant Cell Tumors of the Distal Radium: A Multicenter Retrospective Study in China. Scientific Reports, 7(1), 1–6. https://doi.org/10.1038/s41598-017-09486-6

. Salsabila, J. (2020). Prevalensi dan Karakteristik Klinis Giant Cell Tumor of Bone di RSUP Dr. Mohammad Hoesin Palembang Periode 2 Januari 2015-31 Desember 2019

. Mavrogenis, A. F., Igoumenou, V. G., Megaloikonomos, P. D., Panagopoulos, G. N., Papagelopoulos, P. J., & Soucacos, P. N. (2017). Giant cell tumor of bone revisited. Sicot-J, 3. https://doi.org/10.1051/sicotj/2017041

. Georgiev, GP, Slavchev, S., Dimitrova, I., & Landzhov, B. (2015). Giant cell tumor of bone: current review of morphological, clinical, radiological, and therapeutic characteristics. Journal of Clinical and Experimental Investigations, 5(3), 475–485. https://doi.org/10.5799/ahinjs.01.2014.03.0445

Published
2022-05-28
How to Cite
Futriani, Muhammad P. Johan, Ni Ketut Sungowati, Andi A. Zainuddin, Djumadi Achmad, & Upik A. Miskad. (2022). Clinical Characteristics of Giant Cell Tumour of Bone in Makassar, Indonesia. International Journal of Sciences: Basic and Applied Research (IJSBAR), 62(2), 177-181. Retrieved from https://gssrr.org/index.php/JournalOfBasicAndApplied/article/view/14103
Section
Articles